February 10, 2023
Lasco Manufacturing Limited (LASM)
Financials for the nine months ended December 31, 2022:
Lasco Manufacturing Limited (LASM) for the nine months ended December 31, 2022, recorded an 18% increase in revenue to total $8.33 billion relative to the $7.05 billion recorded for the comparable period in 2021. For the third quarter, total revenue closed at $2.86 billion (2021: $2.40 billion), a 19% rise year over year.
Cost of sales amounted to $5.28 billion (2021: $4.42 billion) for the period, an increase of 19% year on year. As a result, gross profit of $3.05 billion was recorded for the period, 16% more than the $2.63 billion booked in December 2021. For the quarter, gross profit increase by 17% to close at $1.08 billion (2021: $919.99 million). LASM noted, “the gross margin for the three months was 37% comparable to the same period last year.”
LASM posted other operating losses of $35.05 million, compared to other operating income of $67.38 million reported for the prior year. For the quarter, other operating loss totaled $11.36 million in contrast to other operating income of $16.40 million in the previous comparable quarter.
Operating expenses closed the period at $1.04 billion compared to $950.24 million booked for the corresponding period last year. Operating expenses for Q3 increased by 8% to $352.77 million (2021: $327.35 million).
Consequently, LASM recorded operating profit of $1.97 billion, 13% higher than the $1.75 billion booked in 2021. Q3 operating profit increased 17% to $715.12 million relative to $609.05 million in the prior comparable quarter.
Finance costs for the nine months declined by 51% to $19.83 million compared to $40.40 million in the prior year’s comparable period. In the third quarter, finance costs declined 56% to $5.03 million (2021: $11.32 million).
As such, profit before taxation amounted to $1.95 billion, an increase of 14% from the $1.71 billion recorded for the previous year. Taxes recorded for the period amounted to $583.10 million (2021: $521.45 million). As a result, net profit for the nine month period totaled $1.37 billion compared to $1.19 billion in 2021, an increase of 16% year over year. While, for the third quarter, net profit closed at $487.57 million (2021: $403.29 million), up by 21%.
Consequently, Earnings per share for the period ended December 31, 2022 amounted to $0.33 relative to $0.29 in 2021. For the quarter, Earnings per share totaled to $0.12 (2021: $0.10). The trailing twelve months EPS amounts to $0.46. The number of shares used in the calculations amounted to 4,132,913,151 units. The stock price closed trading on February 9, 2022 at $4.29 with a corresponding P/E of 9.37 times.
Balance sheet at a Glance:
Total assets increased 12% year on year, totalling $12.99 billion as at December 31, 2022 (2021: $11.64 billion). The increase in total assets was mainly due to a 329% increase in ‘Short-term investments’ to total $1.62 billion (2021: $376.48 million). ‘Long term investments’ and ‘Inventories’ also contributed to the growth closing at $644.92 million (2021: $221.03 million) and $1.99 billion (2021: 1.58 billion), respectively.
Total shareholders’ equity amounted to $10.40 billion as at December 31, 2022 (2021: $8.80 billion). Consequently, book value per share amounted to $2.52 relative to $2.13 in 2021.
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may affect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.